▶ 調査レポート

世界の動物血漿&誘導体市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Animal Blood Plasma and Derivatives Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の動物血漿&誘導体市場規模・現状・予測(2021年-2027年) / Global Animal Blood Plasma and Derivatives Market Size, Status and Forecast 2021-2027 / QFJ1-3809資料のイメージです。• レポートコード:QFJ1-3809
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、動物血漿&誘導体の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(免疫グロブリン、フィブリノーゲン、血清アルブミン、ウシ胎児血清、トロンビン、新生子牛血清)、用途別市場規模(食品&飲料産業、医薬品、化粧品、飼料、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・動物血漿&誘導体の市場動向
・企業の競争状況、市場シェア
・動物血漿&誘導体の種類別市場規模と予測2016-2027(免疫グロブリン、フィブリノーゲン、血清アルブミン、ウシ胎児血清、トロンビン、新生子牛血清)
・動物血漿&誘導体の用途別市場規模と予測2016-2027(食品&飲料産業、医薬品、化粧品、飼料、その他)
・動物血漿&誘導体の北米市場規模2016-2027(アメリカ、カナダ)
・動物血漿&誘導体の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・動物血漿&誘導体のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・動物血漿&誘導体の中南米市場規模2016-2027(メキシコ、ブラジル)
・動物血漿&誘導体の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Proliant Inc.、Thermo Fisher Scientific, Inc.、Merck KGaA、Kraeber & Co GmbH、LAMPIRE Biological Laboratories, Inc.、Lake Immunogenics, Inc.、Rocky Mountain Biologicals Inc.、ANZCO Foods Ltd.、Auckland BioSciences Ltd.、Bovogen Biologicals Pty Ltd.)
・結論

Market Analysis and Insights: Global Animal Blood Plasma and Derivatives Market
The global Animal Blood Plasma and Derivatives market size is projected to reach US$ 1343.1 million by 2027, from US$ 981.1 million in 2020, at a CAGR of 4.5% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Animal Blood Plasma and Derivatives market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Animal Blood Plasma and Derivatives market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Animal Blood Plasma and Derivatives market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Animal Blood Plasma and Derivatives market.

Global Animal Blood Plasma and Derivatives Scope and Market Size
Animal Blood Plasma and Derivatives market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Animal Blood Plasma and Derivatives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunoglobulin
Fibrinogen
Serum Albumin
Fetal Bovine Serum
Thrombin
New Born Calf Serum

Segment by Application
Food & Beverages
Pharmaceuticals
Cosmetics
Feed
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Proliant Inc.
Thermo Fisher Scientific, Inc.
Merck KGaA
Kraeber & Co GmbH
LAMPIRE Biological Laboratories, Inc.
Lake Immunogenics, Inc.
Rocky Mountain Biologicals Inc.
ANZCO Foods Ltd.
Auckland BioSciences Ltd.
Bovogen Biologicals Pty Ltd.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunoglobulin
1.2.3 Fibrinogen
1.2.4 Serum Albumin
1.2.5 Fetal Bovine Serum
1.2.6 Thrombin
1.2.7 New Born Calf Serum
1.3 Market by Application
1.3.1 Global Animal Blood Plasma and Derivatives Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Food & Beverages
1.3.3 Pharmaceuticals
1.3.4 Cosmetics
1.3.5 Feed
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Animal Blood Plasma and Derivatives Market Perspective (2016-2027)
2.2 Animal Blood Plasma and Derivatives Growth Trends by Regions
2.2.1 Animal Blood Plasma and Derivatives Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Animal Blood Plasma and Derivatives Historic Market Share by Regions (2016-2021)
2.2.3 Animal Blood Plasma and Derivatives Forecasted Market Size by Regions (2022-2027)
2.3 Animal Blood Plasma and Derivatives Industry Dynamic
2.3.1 Animal Blood Plasma and Derivatives Market Trends
2.3.2 Animal Blood Plasma and Derivatives Market Drivers
2.3.3 Animal Blood Plasma and Derivatives Market Challenges
2.3.4 Animal Blood Plasma and Derivatives Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Animal Blood Plasma and Derivatives Players by Revenue
3.1.1 Global Top Animal Blood Plasma and Derivatives Players by Revenue (2016-2021)
3.1.2 Global Animal Blood Plasma and Derivatives Revenue Market Share by Players (2016-2021)
3.2 Global Animal Blood Plasma and Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Animal Blood Plasma and Derivatives Revenue
3.4 Global Animal Blood Plasma and Derivatives Market Concentration Ratio
3.4.1 Global Animal Blood Plasma and Derivatives Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Animal Blood Plasma and Derivatives Revenue in 2020
3.5 Animal Blood Plasma and Derivatives Key Players Head office and Area Served
3.6 Key Players Animal Blood Plasma and Derivatives Product Solution and Service
3.7 Date of Enter into Animal Blood Plasma and Derivatives Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Animal Blood Plasma and Derivatives Breakdown Data by Type
4.1 Global Animal Blood Plasma and Derivatives Historic Market Size by Type (2016-2021)
4.2 Global Animal Blood Plasma and Derivatives Forecasted Market Size by Type (2022-2027)

5 Animal Blood Plasma and Derivatives Breakdown Data by Application
5.1 Global Animal Blood Plasma and Derivatives Historic Market Size by Application (2016-2021)
5.2 Global Animal Blood Plasma and Derivatives Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Animal Blood Plasma and Derivatives Market Size (2016-2027)
6.2 North America Animal Blood Plasma and Derivatives Market Size by Type
6.2.1 North America Animal Blood Plasma and Derivatives Market Size by Type (2016-2021)
6.2.2 North America Animal Blood Plasma and Derivatives Market Size by Type (2022-2027)
6.2.3 North America Animal Blood Plasma and Derivatives Market Size by Type (2016-2027)
6.3 North America Animal Blood Plasma and Derivatives Market Size by Application
6.3.1 North America Animal Blood Plasma and Derivatives Market Size by Application (2016-2021)
6.3.2 North America Animal Blood Plasma and Derivatives Market Size by Application (2022-2027)
6.3.3 North America Animal Blood Plasma and Derivatives Market Size by Application (2016-2027)
6.4 North America Animal Blood Plasma and Derivatives Market Size by Country
6.4.1 North America Animal Blood Plasma and Derivatives Market Size by Country (2016-2021)
6.4.2 North America Animal Blood Plasma and Derivatives Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Animal Blood Plasma and Derivatives Market Size (2016-2027)
7.2 Europe Animal Blood Plasma and Derivatives Market Size by Type
7.2.1 Europe Animal Blood Plasma and Derivatives Market Size by Type (2016-2021)
7.2.2 Europe Animal Blood Plasma and Derivatives Market Size by Type (2022-2027)
7.2.3 Europe Animal Blood Plasma and Derivatives Market Size by Type (2016-2027)
7.3 Europe Animal Blood Plasma and Derivatives Market Size by Application
7.3.1 Europe Animal Blood Plasma and Derivatives Market Size by Application (2016-2021)
7.3.2 Europe Animal Blood Plasma and Derivatives Market Size by Application (2022-2027)
7.3.3 Europe Animal Blood Plasma and Derivatives Market Size by Application (2016-2027)
7.4 Europe Animal Blood Plasma and Derivatives Market Size by Country
7.4.1 Europe Animal Blood Plasma and Derivatives Market Size by Country (2016-2021)
7.4.2 Europe Animal Blood Plasma and Derivatives Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Animal Blood Plasma and Derivatives Market Size (2016-2027)
8.2 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Type
8.2.1 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Type (2016-2027)
8.3 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Application
8.3.1 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Application (2016-2027)
8.4 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region
8.4.1 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Animal Blood Plasma and Derivatives Market Size (2016-2027)
9.2 Latin America Animal Blood Plasma and Derivatives Market Size by Type
9.2.1 Latin America Animal Blood Plasma and Derivatives Market Size by Type (2016-2021)
9.2.2 Latin America Animal Blood Plasma and Derivatives Market Size by Type (2022-2027)
9.2.3 Latin America Animal Blood Plasma and Derivatives Market Size by Type (2016-2027)
9.3 Latin America Animal Blood Plasma and Derivatives Market Size by Application
9.3.1 Latin America Animal Blood Plasma and Derivatives Market Size by Application (2016-2021)
9.3.2 Latin America Animal Blood Plasma and Derivatives Market Size by Application (2022-2027)
9.3.3 Latin America Animal Blood Plasma and Derivatives Market Size by Application (2016-2027)
9.4 Latin America Animal Blood Plasma and Derivatives Market Size by Country
9.4.1 Latin America Animal Blood Plasma and Derivatives Market Size by Country (2016-2021)
9.4.2 Latin America Animal Blood Plasma and Derivatives Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Animal Blood Plasma and Derivatives Market Size (2016-2027)
10.2 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Type
10.2.1 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Type (2016-2027)
10.3 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Application
10.3.1 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Application (2016-2027)
10.4 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country
10.4.1 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Proliant Inc.
11.1.1 Proliant Inc. Company Details
11.1.2 Proliant Inc. Business Overview
11.1.3 Proliant Inc. Animal Blood Plasma and Derivatives Introduction
11.1.4 Proliant Inc. Revenue in Animal Blood Plasma and Derivatives Business (2016-2021)
11.1.5 Proliant Inc. Recent Development
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Company Details
11.2.2 Thermo Fisher Scientific, Inc. Business Overview
11.2.3 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Introduction
11.2.4 Thermo Fisher Scientific, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2016-2021)
11.2.5 Thermo Fisher Scientific, Inc. Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Animal Blood Plasma and Derivatives Introduction
11.3.4 Merck KGaA Revenue in Animal Blood Plasma and Derivatives Business (2016-2021)
11.3.5 Merck KGaA Recent Development
11.4 Kraeber & Co GmbH
11.4.1 Kraeber & Co GmbH Company Details
11.4.2 Kraeber & Co GmbH Business Overview
11.4.3 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Introduction
11.4.4 Kraeber & Co GmbH Revenue in Animal Blood Plasma and Derivatives Business (2016-2021)
11.4.5 Kraeber & Co GmbH Recent Development
11.5 LAMPIRE Biological Laboratories, Inc.
11.5.1 LAMPIRE Biological Laboratories, Inc. Company Details
11.5.2 LAMPIRE Biological Laboratories, Inc. Business Overview
11.5.3 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Introduction
11.5.4 LAMPIRE Biological Laboratories, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2016-2021)
11.5.5 LAMPIRE Biological Laboratories, Inc. Recent Development
11.6 Lake Immunogenics, Inc.
11.6.1 Lake Immunogenics, Inc. Company Details
11.6.2 Lake Immunogenics, Inc. Business Overview
11.6.3 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Introduction
11.6.4 Lake Immunogenics, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2016-2021)
11.6.5 Lake Immunogenics, Inc. Recent Development
11.7 Rocky Mountain Biologicals Inc.
11.7.1 Rocky Mountain Biologicals Inc. Company Details
11.7.2 Rocky Mountain Biologicals Inc. Business Overview
11.7.3 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Introduction
11.7.4 Rocky Mountain Biologicals Inc. Revenue in Animal Blood Plasma and Derivatives Business (2016-2021)
11.7.5 Rocky Mountain Biologicals Inc. Recent Development
11.8 ANZCO Foods Ltd.
11.8.1 ANZCO Foods Ltd. Company Details
11.8.2 ANZCO Foods Ltd. Business Overview
11.8.3 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Introduction
11.8.4 ANZCO Foods Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2016-2021)
11.8.5 ANZCO Foods Ltd. Recent Development
11.9 Auckland BioSciences Ltd.
11.9.1 Auckland BioSciences Ltd. Company Details
11.9.2 Auckland BioSciences Ltd. Business Overview
11.9.3 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Introduction
11.9.4 Auckland BioSciences Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2016-2021)
11.9.5 Auckland BioSciences Ltd. Recent Development
11.10 Bovogen Biologicals Pty Ltd.
11.10.1 Bovogen Biologicals Pty Ltd. Company Details
11.10.2 Bovogen Biologicals Pty Ltd. Business Overview
11.10.3 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Introduction
11.10.4 Bovogen Biologicals Pty Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2016-2021)
11.10.5 Bovogen Biologicals Pty Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunoglobulin
Table 3. Key Players of Fibrinogen
Table 4. Key Players of Serum Albumin
Table 5. Key Players of Fetal Bovine Serum
Table 6. Key Players of Thrombin
Table 7. Key Players of New Born Calf Serum
Table 8. Global Animal Blood Plasma and Derivatives Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Animal Blood Plasma and Derivatives Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Animal Blood Plasma and Derivatives Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Animal Blood Plasma and Derivatives Market Share by Regions (2016-2021)
Table 12. Global Animal Blood Plasma and Derivatives Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Animal Blood Plasma and Derivatives Market Share by Regions (2022-2027)
Table 14. Animal Blood Plasma and Derivatives Market Trends
Table 15. Animal Blood Plasma and Derivatives Market Drivers
Table 16. Animal Blood Plasma and Derivatives Market Challenges
Table 17. Animal Blood Plasma and Derivatives Market Restraints
Table 18. Global Animal Blood Plasma and Derivatives Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Animal Blood Plasma and Derivatives Market Share by Players (2016-2021)
Table 20. Global Top Animal Blood Plasma and Derivatives Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Animal Blood Plasma and Derivatives as of 2020)
Table 21. Ranking of Global Top Animal Blood Plasma and Derivatives Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Animal Blood Plasma and Derivatives Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Animal Blood Plasma and Derivatives Product Solution and Service
Table 25. Date of Enter into Animal Blood Plasma and Derivatives Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Animal Blood Plasma and Derivatives Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Animal Blood Plasma and Derivatives Revenue Market Share by Type (2016-2021)
Table 29. Global Animal Blood Plasma and Derivatives Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Animal Blood Plasma and Derivatives Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Animal Blood Plasma and Derivatives Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Animal Blood Plasma and Derivatives Revenue Market Share by Application (2016-2021)
Table 33. Global Animal Blood Plasma and Derivatives Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Animal Blood Plasma and Derivatives Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Animal Blood Plasma and Derivatives Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Animal Blood Plasma and Derivatives Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Animal Blood Plasma and Derivatives Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Animal Blood Plasma and Derivatives Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Animal Blood Plasma and Derivatives Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Animal Blood Plasma and Derivatives Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Animal Blood Plasma and Derivatives Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Animal Blood Plasma and Derivatives Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Animal Blood Plasma and Derivatives Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Animal Blood Plasma and Derivatives Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Animal Blood Plasma and Derivatives Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Animal Blood Plasma and Derivatives Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Animal Blood Plasma and Derivatives Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Animal Blood Plasma and Derivatives Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Animal Blood Plasma and Derivatives Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Animal Blood Plasma and Derivatives Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Animal Blood Plasma and Derivatives Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Animal Blood Plasma and Derivatives Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2022-2027) & (US$ Million)
Table 65. Proliant Inc. Company Details
Table 66. Proliant Inc. Business Overview
Table 67. Proliant Inc. Animal Blood Plasma and Derivatives Product
Table 68. Proliant Inc. Revenue in Animal Blood Plasma and Derivatives Business (2016-2021) & (US$ Million)
Table 69. Proliant Inc. Recent Development
Table 70. Thermo Fisher Scientific, Inc. Company Details
Table 71. Thermo Fisher Scientific, Inc. Business Overview
Table 72. Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Product
Table 73. Thermo Fisher Scientific, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2016-2021) & (US$ Million)
Table 74. Thermo Fisher Scientific, Inc. Recent Development
Table 75. Merck KGaA Company Details
Table 76. Merck KGaA Business Overview
Table 77. Merck KGaA Animal Blood Plasma and Derivatives Product
Table 78. Merck KGaA Revenue in Animal Blood Plasma and Derivatives Business (2016-2021) & (US$ Million)
Table 79. Merck KGaA Recent Development
Table 80. Kraeber & Co GmbH Company Details
Table 81. Kraeber & Co GmbH Business Overview
Table 82. Kraeber & Co GmbH Animal Blood Plasma and Derivatives Product
Table 83. Kraeber & Co GmbH Revenue in Animal Blood Plasma and Derivatives Business (2016-2021) & (US$ Million)
Table 84. Kraeber & Co GmbH Recent Development
Table 85. LAMPIRE Biological Laboratories, Inc. Company Details
Table 86. LAMPIRE Biological Laboratories, Inc. Business Overview
Table 87. LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Product
Table 88. LAMPIRE Biological Laboratories, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2016-2021) & (US$ Million)
Table 89. LAMPIRE Biological Laboratories, Inc. Recent Development
Table 90. Lake Immunogenics, Inc. Company Details
Table 91. Lake Immunogenics, Inc. Business Overview
Table 92. Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Product
Table 93. Lake Immunogenics, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2016-2021) & (US$ Million)
Table 94. Lake Immunogenics, Inc. Recent Development
Table 95. Rocky Mountain Biologicals Inc. Company Details
Table 96. Rocky Mountain Biologicals Inc. Business Overview
Table 97. Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Product
Table 98. Rocky Mountain Biologicals Inc. Revenue in Animal Blood Plasma and Derivatives Business (2016-2021) & (US$ Million)
Table 99. Rocky Mountain Biologicals Inc. Recent Development
Table 100. ANZCO Foods Ltd. Company Details
Table 101. ANZCO Foods Ltd. Business Overview
Table 102. ANZCO Foods Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2016-2021) & (US$ Million)
Table 103. ANZCO Foods Ltd. Recent Development
Table 104. Auckland BioSciences Ltd. Company Details
Table 105. Auckland BioSciences Ltd. Business Overview
Table 106. Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Product
Table 107. Auckland BioSciences Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2016-2021) & (US$ Million)
Table 108. Auckland BioSciences Ltd. Recent Development
Table 109. Bovogen Biologicals Pty Ltd. Company Details
Table 110. Bovogen Biologicals Pty Ltd. Business Overview
Table 111. Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Product
Table 112. Bovogen Biologicals Pty Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2016-2021) & (US$ Million)
Table 113. Bovogen Biologicals Pty Ltd. Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Animal Blood Plasma and Derivatives Market Share by Type: 2020 VS 2027
Figure 2. Immunoglobulin Features
Figure 3. Fibrinogen Features
Figure 4. Serum Albumin Features
Figure 5. Fetal Bovine Serum Features
Figure 6. Thrombin Features
Figure 7. New Born Calf Serum Features
Figure 8. Global Animal Blood Plasma and Derivatives Market Share by Application: 2020 VS 2027
Figure 9. Food & Beverages Case Studies
Figure 10. Pharmaceuticals Case Studies
Figure 11. Cosmetics Case Studies
Figure 12. Feed Case Studies
Figure 13. Others Case Studies
Figure 14. Animal Blood Plasma and Derivatives Report Years Considered
Figure 15. Global Animal Blood Plasma and Derivatives Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Animal Blood Plasma and Derivatives Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Animal Blood Plasma and Derivatives Market Share by Regions: 2020 VS 2027
Figure 18. Global Animal Blood Plasma and Derivatives Market Share by Regions (2022-2027)
Figure 19. Global Animal Blood Plasma and Derivatives Market Share by Players in 2020
Figure 20. Global Top Animal Blood Plasma and Derivatives Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Animal Blood Plasma and Derivatives as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Animal Blood Plasma and Derivatives Revenue in 2020
Figure 22. Global Animal Blood Plasma and Derivatives Revenue Market Share by Type (2016-2021)
Figure 23. Global Animal Blood Plasma and Derivatives Revenue Market Share by Type (2022-2027)
Figure 24. North America Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Animal Blood Plasma and Derivatives Market Share by Type (2016-2027)
Figure 26. North America Animal Blood Plasma and Derivatives Market Share by Application (2016-2027)
Figure 27. North America Animal Blood Plasma and Derivatives Market Share by Country (2016-2027)
Figure 28. United States Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Animal Blood Plasma and Derivatives Market Share by Type (2016-2027)
Figure 32. Europe Animal Blood Plasma and Derivatives Market Share by Application (2016-2027)
Figure 33. Europe Animal Blood Plasma and Derivatives Market Share by Country (2016-2027)
Figure 34. Germany Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Animal Blood Plasma and Derivatives Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Animal Blood Plasma and Derivatives Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Animal Blood Plasma and Derivatives Market Share by Region (2016-2027)
Figure 44. China Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Animal Blood Plasma and Derivatives Market Share by Type (2016-2027)
Figure 52. Latin America Animal Blood Plasma and Derivatives Market Share by Application (2016-2027)
Figure 53. Latin America Animal Blood Plasma and Derivatives Market Share by Country (2016-2027)
Figure 54. Mexico Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Animal Blood Plasma and Derivatives Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Animal Blood Plasma and Derivatives Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Animal Blood Plasma and Derivatives Market Share by Country (2016-2027)
Figure 60. Turkey Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Animal Blood Plasma and Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Proliant Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2016-2021)
Figure 64. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2016-2021)
Figure 65. Merck KGaA Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2016-2021)
Figure 66. Kraeber & Co GmbH Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2016-2021)
Figure 67. LAMPIRE Biological Laboratories, Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2016-2021)
Figure 68. Lake Immunogenics, Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2016-2021)
Figure 69. Rocky Mountain Biologicals Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2016-2021)
Figure 70. ANZCO Foods Ltd. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2016-2021)
Figure 71. Auckland BioSciences Ltd. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2016-2021)
Figure 72. Bovogen Biologicals Pty Ltd. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed